FDA inspection
David W. Mayleben PhD: FDA inspection ending Oct 26, 2023
FDA inspection 1221766 · No Action Indicated (NAI) · Cincinnati, OH
Key facts
| Inspection ID | 1221766 |
|---|---|
| Firm | David W. Mayleben PhD |
| FEI number | 3009800605 |
| Address | 1775 Lexington Ave Ste 200 |
| City | Cincinnati |
| State | OH |
| ZIP | 45212 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Oct 26, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data